Culture

New microscopy analysis allows discovery of central adhesion complex

image: The image shows localization clouds of individual adhesion proteins in cells. Many proteins remained undetectable when using conventional analytical methods. By using the new analytical method actual molecular parameters can be determined. Scale bar: 100 nm.

Image: 
Lisa Fischer and Carsten Grashoff

Cells of organisms are organized in subcellular compartments that consist of many individual molecules. How these single proteins are organized on the molecular level remains unclear, because suitable analytical methods are still missing. Researchers at the University of Münster together with colleagues from the Max Planck Institute of Biochemistry (Munich, Germany) have established a new technique that enables quantifying molecular densities and nanoscale organizations of individual proteins inside cells. The first application of this approach reveals a complex of three adhesion proteins that appears to be crucial for the ability of cells to adhere to the surrounding tissue. The research results have been published in the journal Nature Communications.

Background and methodology

The attachment of cells is mediated by multi-molecular adhesion complexes that are built by hundreds of different proteins. The development of super-resolution microscopy, which was honoured with the Nobel Prize in 2014, allowed the identification of basic structural elements within such complexes. However, it remained unclear how individual proteins assemble and co-organize to form functional units. The laboratories of Prof. Dr. Carsten Grashoff at the Institute of Molecular Cell Biology (University of Münster) and Prof. Dr. Ralf Jungmann at the Max Planck Institute of Biochemistry (Munich) now developed a novel approach that allows the visualization and quantification of such molecular processes even in highly crowded subcellular structures.

"A substantial limitation even of the best super-resolution microscopy techniques is that many molecules remain undetected. It is therefore nearly impossible to make quantitative statements about processes of molecular complex formation in cells", explains Lisa Fischer, PhD student in the Grashoff group and first author of the study. This difficulty could now be circumvented with a combination of experimental controls and theoretical considerations.

"By applying our new analytical method, we were able to provide evidence for the existence of a long suspected ternary adhesion complex. We knew already before that each of these three molecules is very important for cell adhesion", explains Fischer. "However, it was not clear whether all three proteins come together to form a functional unit". As the method is broadly applicable, the researchers believe that many other cellular processes will be studied with the new analysis procedure.

Credit: 
University of Münster

People with and without AD have a different threshold for elective revascularisation

The risk of both mortality and rehospitalisation after an elective revascularisation procedure for coronary artery disease is similar for people with and without Alzheimer's disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.

Previous studies have investigated the effectiveness of revascularisation in persons with cognitive disorders, but only in terms of short-term outcomes and in acute care settings, and they also have not accounted for electivity. Similar to previous studies, people with Alzheimer's disease were 76% less likely to undergo a revascularisation procedure and only a third of the procedures were elective, compared to 48.6% of elective procedures in the comparison group without AD.

People with Alzheimer's disease had a higher risk of mortality in the procedural unit, and a 1.42-fold mortality rate during a 3-year follow-up, compared to people without AD. However, the risks were similar for elective procedures in persons with and without AD. Sociodemographic characteristics, comorbidities, statin use, length of stay and required support at discharge were controlled for in the analyses. The results were similar for both revascularisation procedure types studied, i.e., coronary artery bypass graft surgery (CABG) and percutaneous coronary interventions (PCI).

These observations on a lower rate for elective revascularisations and comparable outcomes after revascularisation procedures indicate a different threshold for elective procedures compared to emergency ones, and a very different selection for people with major cognitive disorders.

The study was conducted as part of the Medication Use and Alzheimer's Disease Study (MEDALZ), in a cohort which includes 70,718 Finnish community dwellers with Alzheimer's disease, and a matched comparison cohort. This study was restricted to people who had no previous revascularisation.

Credit: 
University of Eastern Finland

Challenge to anorexia nervosa treatment guidelines

image: Sketch of a patient's perception of living with anorexia nervosa.

Image: 
Professor Tracey Wade, Flinders University

New analysis published in The Lancet Psychiatry has shown a lack of strong evidence to support current guidance on psychological therapies for treating anorexia nervosa over expert treatment as usual.

The findings highlight a need for further research and support a call for individual trial data to be made available so the benefits of treatments in specific patient populations can be better understood.

Conducted by an international team of clinical experts and researchers, the analysis included 13 randomised controlled trials and a total of 1049 patients. The studies compared psychological therapies to treatment as usual in adults receiving outpatient treatment for anorexia. The trials measured eating disorder symptoms, body-mass index (BMI) and all-cause dropout rate up to 52 weeks of follow up.

The analysis found some therapies to have modest benefit to patients. However, the therapies, currently recommended by the National Institute for Clinical Excellence (NICE) and in clinical guidelines internationally, were not shown to differ significantly from expert treatment as usual.

Professor Andrea Cipriani (University of Oxford), lead author on the project, says:

"Understanding the effectiveness of available treatments is particularly important for anorexia nervosa because it has one of the highest mortality rates of any psychiatric condition. This analysis highlights the gaps in existing evidence and the urgent need for more and better research into psychological therapies for treating Anorexia."

Because of the relatively low quality and quantity of data available, this analysis should be understood as exploratory rather than confirmatory. However, it highlights the shortcomings of existing research and emphasises the need for more robust data.

Professor Tracey Wade (Flinders University), lead collaborator on the project, says:

"We have made progress in understanding the effective non-specific factors that need to be included in any treatment for anorexia nervosa. Our future challenge is to develop treatment factors tailored to individual presentations that can be added to the non-specific factors to increase effectiveness of our treatments for the condition."

The research was funded by the NIHR Oxford Health Biomedical Research Centre, the University of Oxford and Flinders University.

* The psychological interventions included in the analysis include Cognitive Behavioural Therapy (CBT), family-oriented treatments, psychodynamic treatments, and other treatments such as Maudsley anorexia nervosa treatment for adults (MANTRA) and specialist supportive clinical management (SSCM).

* Treatment at usual varied between the trials included in the analysis and can involve several components delivered by many people. The poor description of treatment as usual was a limitation observed in most of the trials included in the analysis.

The paper, Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis, published in The Lancet Psychiatry will be available here http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30566-6/fulltext.

Credit: 
Flinders University

Graphene "nano-origami" creates tiniest microchips yet

image: Image reveals the kink in the form of wrinkles that causes change in Raman signals of altered electronic property.

Image: 
University of Sussex

The tiniest microchips yet can be made from graphene and other 2D-materials, using a form of 'nano-origami', physicists at the University of Sussex have found.

This is the first time any researchers have done this, and it is covered in a paper published in the ACS Nano journal.

By creating kinks in the structure of graphene, researchers at the University of Sussex have made the nanomaterial behave like a transistor, and have shown that when a strip of graphene is crinkled in this way, it can behave like a microchip, which is around 100 times smaller than conventional microchips.

Prof Alan Dalton in the School of Mathematical and Physics Sciences at the University of Sussex, said:

"We're mechanically creating kinks in a layer of graphene. It's a bit like nano-origami.

"Using these nanomaterials will make our computer chips smaller and faster. It is absolutely critical that this happens as computer manufacturers are now at the limit of what they can do with traditional semiconducting technology. Ultimately, this will make our computers and phones thousands of times faster in the future.

"This kind of technology - "straintronics" using nanomaterials as opposed to electronics - allows space for more chips inside any device. Everything we want to do with computers - to speed them up - can be done by crinkling graphene like this."

Dr Manoj Tripathi, Research Fellow in Nano-structured Materials at the University of Sussex and lead author on the paper, said:

"Instead of having to add foreign materials into a device, we've shown we can create structures from graphene and other 2D materials simply by adding deliberate kinks into the structure. By making this sort of corrugation we can create a smart electronic component, like a transistor, or a logic gate."

The development is a greener, more sustainable technology. Because no additional materials need to be added, and because this process works at room temperature rather than high temperature, it uses less energy to create.

Credit: 
University of Sussex

Let the immune cell see the virus: Scientists discover unique way to target common virus

Scientists at Cardiff University have discovered a unique way to target a common virus that affects one in 200 newborn babies in the UK but for which there is only limited treatments available.

Human cytomegalovirus (HCMV) is a master at "hiding" from the body's immune system so antibodies and T-cells cannot attack it as they do in other viruses, like the current coronavirus.

The researchers have now discovered a new type of antibody in the lab which - instead of killing the virus directly - marks infected cells so the immune system can "see" them.

Once the immune system can see the infected cells it is able to kill the virus.

The team have submitted a patent for the unique immunotherapeutic and hope it can help to treat HCMV, which can leave newborn babies severely disabled or even kill them.

Further work is needed to make sure it is safe and effective in humans - but the researchers hope the technique could eventually be used to fight other infectious diseases and the method they used to find the new antibody could be applied to cancer.

The study is published today in the Journal of Clinical Investigation.

Lead author Dr Richard Stanton, a virologist from Cardiff University's Division of Infection and Immunity, said: "HCMV is a major challenge because it has evolved a range of different techniques to avoid the body's own immune response.

"We have developed a really unique way of letting the immune system see the virus so it can get on with its task of killing it."

HCMV causes lifelong infection in humans and is a significant cause of severe disease or death in immunocompromised individuals, such as those undergoing transplants or people with HIV.

A vaccine is paramount to fighting the virus, particularly for tackling congenital disease, however there is currently no vaccine and only limited treatment options are available.

In this study, the researchers looked at whether antibody-dependent cellular cytotoxicity (ADCC) - a particular type of immune response in which a target cell is coated with antibodies and killed by immune cells - could be exploited for therapeutic use.

They used a special technique (proteomics) to characterise the molecules found on the surface of the infected cell and combined this with immunological screening to identify targets for ADCC.

They found a unique target expressed early in the virus's lifecycle and were then able to develop human antibodies for use against this target.

In the lab, this brought about a potent activation of ADCC, killing the infected cells.

"The identification of novel ADCC targets not only opens up a fuller understanding of natural immunity against HCMV that can be exploited for therapeutic benefit, but this could also now be applied to other infectious diseases - and the mechanism we used to pinpoint the new antibody could potentially also work in cancer," said Dr Stanton.

"Further work is now needed to demonstrate both safety and efficacy in humans."

Credit: 
Cardiff University

Heartbeat secrets unlocked as cardiac rhythm gene role identified

Researchers have used the zebrafish (Danio rerio) to identify the role of a gene involved in cardiac rhythm, which could help explain the fundamentals of what it takes to make a human heartbeat.

The University of Melbourne study also found that mutation of the gene, Tmem161b, causes potentially fatal cardiac arrhythmia. 2.5 per cent of Australians are living with cardiac arrhythmia (ABS). In 2019, it took 3090 years of potential life. Mutations in this gene may be contributing to the cause of this.

Published in Proceedings of National Academy of Sciences of the United States of America (PNAS), the research could lead to better understanding and treatment of the condition in humans.

University of Melbourne Associate Professor Kelly Smith said the research discovered what Tmem161b does, when previously we had no idea of its function.

"Zebrafish eggs were used as they have complex beating hearts, similar to humans," Associate Professor Smith said. "Eighty per cent of zebrafish genes are like ours and both use the same basic 'equipment'."

The researchers used naturally produced eggs to observe organ development under a microscope. The eggs are translucent, which allowed observation without interference.

Associate Professor Smith said this important discovery would improve our knowledge of the heartbeat.

"What's important is, it describes a new gene in cardiac rhythm, which helps us to understand the fundamentals of what it takes to make a heartbeat," Associate Professor Smith said.

"Until now, no-one has known what it does, which makes this research so exciting.

"We screened thousands of zebrafish families and found one with inherited arrhythmia. Working backwards from there, we found which gene was mutated to cause the arrhythmia. It turned out to be a gene that was completely uncharacterised."

Associate Professor Smith said she suspected the finding would be relevant in humans.

"Given the prevalence of cardiac arrhythmia in Australia, the more we know about how the heart works, the better," she said.

"The gene described in the research appears to play a central function, so we expect it to be important in more than just controlling heart rhythm. But that will take time to explore.

"If this turns out to be significant in humans, it will provide a new candidate for genetic screening of patients with cardiac arrhythmias."

Credit: 
University of Melbourne

Almost half of virus sufferers report depression

Almost half of people testing positive for coronavirus have reported symptoms of depression, according to a new study published in the International Journal of Environmental Research and Public Health.

Researchers from Bangladesh, the United States and Anglia Ruskin University (ARU) in the UK carried out a cross-sectional survey of more than 1,000 Bangladeshi adult coronavirus patients over the course of one month.

A total of 48% of respondents were categorised as having moderate to severe depression, with a higher prevalence in those with persistent symptoms, low family income and poor health status.

A fifth of those surveyed reported having persistent COVID-19 symptoms, the most common of these being diarrhoea and fatigue. Around a quarter of patients had attempted to self-medicate their symptoms with over-the-counter medicines, rather than contact health services.

Co-author Professor Shahina Pardhan, of Anglia Ruskin University, said: "Our study found a high number of respondents suffering depression alongside their COVID-19 symptoms, particularly those who were more vulnerable.

"We know that the World Health Organisation has reported that mental health services across the world have been disrupted by the pandemic, and this study shows the pressing need for these services among those testing positive for the virus."

Credit: 
Anglia Ruskin University

Researchers demonstrate self-sterilizing polymers work against SARS-CoV-2

Researchers from North Carolina State University, Boston University and Kraton Corporation have demonstrated a family of self-sterilizing polymers that are effective at inactivating coronaviruses, including SARS-CoV-2 - the virus that causes COVID-19. The work opens the door to a suite of applications that could help to reduce the transmission of COVID-19 and other diseases.

"Our work here provides conclusive evidence that these materials, anionic polymers, can inactivate human coronaviruses quickly and efficiently," says Richard Spontak, co-author of a paper on the work accepted for publication in Advanced Science. Spontak is a Distinguished Professor of Chemical and Biomolecular Engineering and a professor of materials science and engineering at North Carolina State University.

"If we want to coat high-contact surfaces such as textiles, countertops or walls - it's possible," says Frank Scholle, co-author of the paper and an associate professor of biological sciences at NC State. "Virus inactivation will occur as long as there is sufficient humidity," adds Scholle, who is also director of NC State's Center for Advanced Virus Experimentation (CAVE).

When these anionic polymers absorb water, protons can travel through nanoscale channels to the surface, creating a highly acidic environment capable of inactivating viruses and killing bacteria and mold. The research team had previously demonstrated that several of the anionic polymers were effective against a range of pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and a strain of influenza.

"Based on what we've learned, we've been able to identify a fundamentally new inactivation mechanism and a family of polymers that expands the health care sector's arsenal for fighting the spread of coronavirus," Spontak says.

In laboratory experiments, the researchers demonstrated that specific anionic polymers could fully inactivate SARS-CoV-2 in just 5 minutes, and fully inactivate a human coronavirus surrogate called HCoV-229E in 20 minutes.

Kraton Corporation is in the process of evaluating applications for how some of these polymers might be used in a variety of settings.

"We are thankful for the opportunity to collaborate with NC State University and Boston University to address an important and urgent need for long-lasting antimicrobial performance," says Vijay Mhetar, Kraton's Chief Technology Officer. "Building upon this scientific discovery, Kraton Corporation is actively seeking regulatory approvals and evaluating application uses in transportation, health care, and building and infrastructure."

Credit: 
North Carolina State University

Oncotarget: Cancer stem cells and macrophages against cancer

image: Main roles of tumor associated macrophages in cancer development and manteinance. TAMs and their released factors are involved in different processes controlling the evolution of cancer. Schematic representation of the role of TAMs in tumor growth, angiogenesis, invasion, metastasis and regulation of T lymphocytes.

Image: 
Correspondence to - Beatrice Aramini - beatrice.aramini@unimore.it

Here is a link to watch a video interview with Dr. Beatrice Aramini about this topic on the Oncotarget YouTube Channel

Oncotarget published "Cancer stem cells and macrophages: molecular connections and future perspectives against cancer" which reported that Cancer stem cells have been considered the key drivers of cancer initiation and progression due to their unlimited self-renewal capacity and their ability to induce tumor formation.

Macrophages, particularly tumor-associated macrophages, establish a tumor microenvironment to protect and induce CSCs development and dissemination.

Many studies in the past decade have been performed to understand the molecular mediators of CSCs and TAMs, and several studies have elucidated the complex crosstalk that occurs between these two cell types.

The aim of this Oncotarget review is to define the complex crosstalk between these two cell types and to highlight potential future anti-cancer strategies.

The aim of this Oncotarget review is to define the complex crosstalk between these two cell types and to highlight potential future anti-cancer strategies

Dr. Beatrice Aramini from The University of Modena and Reggio Emilia said, "Cancer stem cells (CSCs) constitute a cancer cell subpopulation similar to the other stem cell types in terms of self-renewal and multilineage differentiation potential but drive tumor development besides heterogeneity and dissemination of cancer cells."

The role of ALDH as a possible marker for lung cancer stem cell: as ALDH cells in cancer cell lines, as well as those extracted from lung cancer tissue, for the properties that it showed as forming spheres in culture tumor cells lines as well as in cells extracted from lung cancer tissue.

However, currently there is no specific or standard marker in lung cancer cells that can define this subpopulation of cells, probably due to the complex localization of these markers and their epigenetic regulation.

A theory regarding the role of CSCs in cancer progression is based on the premise that tumor tissue is hierarchically organized into different types of cells wherein CSC subpopulation is at the top of this hierarchy, with the other levels consisting of more differentiated tumor cells or cells with a limited proliferative potential.

Another essential characteristic that places CSCs at the top of the tumor cell hierarchy is their unlimited proliferation potential, which allows them to repopulate the tumor even if bulk tumor cells have been removed.

The Aramini Research Team concluded in their Oncotarget Review, "Generating new information about the interaction between TAMs and CSCs will be one of the most important challenges for the development of more effective targeted cancer therapies."

Sign up for free Altmetric alerts about this article

DOI - https://doi.org/10.18632/oncotarget.27870

Full text - https://www.oncotarget.com/article/27870/text/

Correspondence to - Beatrice Aramini - beatrice.aramini@unimore.it

Keywords -
cancer stem cells,
macrophages,
future perspectives,
cancer,
target treatments

About Oncotarget

Oncotarget is a weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:

SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls

Journal

Oncotarget

DOI

10.18632/oncotarget.27870

Credit: 
Impact Journals LLC

Large-scale study finds genetic testing technology falsely detects very rare variants

A technology that is widely used by commercial genetic testing companies is "extremely unreliable" in detecting very rare variants, meaning results suggesting individuals carry rare disease-causing genetic variants are usually wrong, according to new research published in the BMJ.

After hearing of cases where women had surgery scheduled after wrongly being told they had very rare genetic variations in the gene BRCA1 that could significantly increase risk of breast cancer, a team at the University of Exeter conducted a large-scale analysis of the technology using data from nearly 50,000 people. They found that the technology wrongly identified the presence of very rare genetic variants in the majority of cases.

The team analysed SNP chips, which test genetic variation at hundreds-of-thousands of specific locations across the genome. While excellent at detecting common genetic variation that can increase the risk of diseases such as type 2 diabetes, geneticists have long known they are less reliable at detecting rarer variation. However, this problem is less well known outside the genetic research community, and SNP chips are widely used by commercial companies that offer genetic testing direct to consumers.

Caroline Wright, Professor in Genomic Medicine at the University of Exeter Medical School, senior author on the paper, said: "SNP chips are fantastic at detecting common genetic variants, yet we have to recognise that tests that perform well in one scenario are not necessarily applicable to others. We've confirmed that SNP chips are extremely poor at detecting very rare disease-causing genetic variants, often giving false positive results that can have profound clinical impact. These false results had been used to schedule invasive medical procedures that were both unnecessary and unwarranted."

The team compared data from SNP chips with data from the more reliable tool of next generation sequencing in 49,908 participants of UK Biobank, and an additional 21 people who shared results of their consumer genetic tests via the Personal Genome Project.

The study concluded that SNP chips performed extremely well in detecting common genetic variants. However, the rarer the variation was, the less reliable the results became. In very rare variants, present in fewer than 1 in 100,000 individuals, typical of those causing rare genetic disease, 84 per cent were false positives in UK Biobank. In the data from commercial customers, 20 of 21 individuals analysed had at least one false positive rare disease-causing variant that had been incorrectly genotyped.

Dr Leigh Jackson, Lecturer in Genomic Medicine at the University of Exeter and co-author of the paper, said: "The number of false positives on rare genetic variants produced by SNP chips was shockingly high. To be clear: a very rare, disease-causing variant detected using a SNP chip is more likely to be wrong than right. Although some consumer genomics companies perform sequencing to validate important results before releasing them to consumers, most consumers also download their "raw" SNP chip data for secondary analysis, and this raw data still contain these incorrect results. The implications of our findings are very simple: SNP chips perform poorly for detecting very rare genetic variants and the results should never be used to guide a patient's medical care, unless they have been validated."

Credit: 
University of Exeter

Drinking, smoking, and drug use linked to premature heart disease in the young

Recreational drinking, smoking, and drug use is linked to premature heart disease in young people, particularly younger women, finds research published online in the journal Heart.

Those who regularly use 4 or more substances are 9 times as likely to be affected, the findings indicate.

The numbers of new cases of heart disease (atherosclerotic cardiovascular disease) have been increasing in young adults, but the potential role of recreational substance use isn't entirely clear.

To probe this further, the researchers explored whether the recreational use of tobacco, cannabis, alcohol, and illicit drugs, such as amphetamine and cocaine, might be linked to prematurely and extremely prematurely furred up arteries.

They drew on information supplied to the 2014-2015 nationwide Veterans Affairs Healthcare database and the Veterans with premaTure AtheroscLerosis (VITAL) registry.

Extremely premature heart disease was defined as an 'event', such as a heart attack, angina, or stroke before the age of 40, while premature heart disease was defined as an event before the age of 55 in men and before the age of 65 in women.

In all, there were 135,703 people with premature heart disease and 7716 with extremely premature heart disease. They were compared with 1,112, 45 patients who didn't have premature heart disease.

Recreational use of any substance was independently associated with a higher likelihood of premature and extremely premature heart disease.

Patients with premature heart disease were more likely to smoke (63% vs 41%), drink (32% vs 15%), and to use cocaine (13% vs 2.5%), amphetamines (3% vs 0.5%), and cannabis (12.5% vs 3%).

After accounting for potentially influential factors, such as high blood pressure, diabetes, and high cholesterol, those who smoked tobacco were nearly twice as likely to have premature heart disease while those who drank recreationally were 50% more likely to do so.

Cocaine users were almost 2.5 times as likely to have premature heart disease, while those who used amphetamines were nearly 3 times as likely to do so. Cannabis users were more than 2.5 times as likely to have premature heart disease while those using other drugs were around 2.5 times as likely to do so.

The higher the number of substances used recreationally, the greater was the risk of premature heart disease, ranging from a doubling in risk with the use of 1 substance to a 9-fold heightened risk for those using 4 or more.

Similar trends were observed among those who had extremely premature heart disease, with recreational substance use associated with 1.5 to 3 times higher odds of heart disease.

The associations were even stronger among women with premature and extremely premature heart disease than among similarly affected men.

This is an observational study, and as such can't establish causality. And the researchers acknowledge that they were unable to gather information on other potentially influential factors, such as the dose and duration of recreational substance use.

In a linked editorial, Dr Anthony Wayne Orr of LSU Health Shreveport, Louisiana, points out that use of cocaine and methamphetamine have been associated with faster cell ageing and neurocognitive decline, with higher than average loss of grey matter.

And epidemiological studies suggest that 1 in 5 young adults misuse several substances and that these 'polysubstance users' often start using at younger ages, and so have worse health over the long term, he says.

The growing body of published research on these issues "suggests the need for a nationwide education campaign on the potential long-term damage being done to the cardiovascular system in patients with substance use disorders," he argues.

These people need to be aware of the long term consequences for their health beyond the risk of an overdose, while doctors should screen patients with a history of substance misuse, he says.

"We are only young once, and we should do everything in our power to maintain that state as long as we can," he concludes.

Credit: 
BMJ Group

Ageism and sexism barring grandmothers from initiatives to save newborn lives in Global South

Ageism, sexism, and Western ideals of the nuclear family have excluded grandmothers from national and international policy initiatives to save newborn lives in the Global South, suggests an analysis published in the online journal BMJ Global Health.

This is despite published research indicating that they are a valuable and influential resource for children's health and survival in many cultures, the study author points out.

Around three out of 4 newborn deaths in the Global South occur in the first week of life--40% of them on the first day, and most of them at home.

But Initiatives to promote the survival of newborns across the Global South have primarily focused on strengthening health services and on young mothers within a nuclear family unit, to the exclusion of caregiver roles and practices within the wider family, says the author.

And extra funds invested in programmes to cut the newborn death rate have had relatively little impact.

To explore the role of the wider family in the care of newborns, and specifically that of grandmothers, the author reviewed relevant published studies of 70 different cultures in the three continents of Africa, Asia, and Latin America.

Cultures in the Global South tend to be collectivist rather than individualist, as in the West. They feature hierarchy based on age and experience, with elders as teachers of younger generations, and interdependency and shared decision-making valued over autonomy.

The studies revealed that grandmothers' knowledge is not always up to date and that some of their newborn practices may be harmful.

But where initiatives have recognised the value of grandmothers, such as in Nepal, Uttar Pradesh in India, Malawi, Burkina Faso and Senegal, these have been successful and prove that grandmothers may not be as resistant to change as is often assumed, notes the author.

The studies also revealed numerous examples of the significant role and influence of experienced older women, or grandmothers, on newborn care, both as authoritative advisors and direct caregivers within multi-generational family systems.

These roles extend from pregnancy onwards and include care of sick newborns, acting as breastfeeding coaches, and providing vital emotional and social support networks.

And across all three continents, the studies showed that grandmothers have similar core roles in newborn care, irrespective of variations in cultural practice.

"A growing body of evidence from across non-western, collectivist societies reveals the culturally designated role of these experienced, older women as newborn advisors and caregivers," writes the author.

"Unfortunately, at the global level, newborn research, policies and interventions continue to focus primarily on medical technologies and services, [and] to a lesser extent on mothers."

She adds: "While all research reviewed provides evidence of grandmothers' influence on newborn care, surprisingly, some does not explicitly recommend their inclusion in future programmes.

"Unfortunately, there is continued reluctance to explicitly involve grandmothers in interventions addressing newborn and other [mother and child health] issues.

"This appears to be related to: the often-repeated idea that grandmothers are barriers to change; a narrow perception of grandmothers focusing on their harmful traditional practices; and gender and ageist biases toward older women."

Future research should be grounded within a family systems framework that reflects collectivist cultures, argues the author.

And initiatives to save newborn lives should "aim not only to strengthen health services, but also influential family caregivers, particularly grandmothers and the indigenous social support networks of which they are a part," she concludes.

Credit: 
BMJ Group

Study questions whether pubs can effectively prevent COVID-19 transmission risk

image: Professor Niamh Fitzgerald

Image: 
University of Stirling

A new first-of-its-kind study has questioned whether pub operators can effectively and consistently prevent COVID-19 transmission - after researchers observed risks arising in licensed premises last summer.

Led by the University of Stirling, the research was conducted in May to August last year in a wide range of licensed premises which re-opened after a nationwide lockdown, and were operating under detailed guidance from government intended to reduce transmission risks.

While observed venues had made physical and operational modifications on re-opening, researchers found that practices were variable and a number of incidents of greater concern were observed - these included close physical interaction between customers and with staff, which frequently involved alcohol intoxication and were rarely effectively stopped by staff.

The new study - published in the Journal of Studies on Alcohol and Drugs - is the first in the world to examine the operation of COVID-19 measures in licensed premises and its findings will inform governments, public health experts, and policymakers in the UK and other countries as they consider the impact of the pandemic on hospitality and the risks of lifting restrictions.

Professor Niamh Fitzgerald, Director of the University of Stirling's Institute for Social Marketing and Health, led the research, which was funded by the Scottish Government Chief Scientist Office.

Professor Fitzgerald said: "Our study explored and observed business practices and behaviours of customers and staff in licensed premises in summer 2020 with a view to understanding if and how COVID-19 transmission risks could be managed in settings where alcohol is served. We interviewed business owners and representatives prior to re-opening to understand the challenges being faced. When pubs reopened last July, following the initial UK lockdown, our team visited premises to observe how government measures designed to reduce transmission risks in hospitality settings were working in practice, including any incidents likely to increase those risks.

"Businesses expressed an intention to work within the guidance, but there were commercial and practical challenges to making this a reality. Upon re-opening, substantial efforts to change the layout of bars were observed and appeared to be working well in many premises, but problems were common including staff not wearing personal protective equipment, or with the management of toilets, queues and other 'pinch points'. We also observed several incidents of greater concern -including customers shouting, embracing or repeatedly interacting closely with several households and staff - which were rarely addressed by staff.

"We concluded that, despite the efforts of bar operators and guidance from government, potentially significant risks of COVID-19 transmission persisted in at least a substantial minority of observed bars, especially when customers were intoxicated. Closures of premises can eliminate these risks, but also cause significant hardship for business owners and staff."

The UK entered national lockdown on March 20 last year. In Scotland, licensed premises were permitted to reopen indoor spaces from July 15, with strict safety rules in place to minimise the risk
of transmission. Premises operating to a one-metre physical distancing limit had to install appropriate signage, all customers had to be seated, staff had to wear face coverings, and improved ventilation and noise reduction measures had to be introduced. Following a large outbreak in early August linked to licensed premises in Aberdeen, it was made a legal requirement for customer details to be collected for contact tracing, and guidance was strengthened around queuing, standing and table service.

Interviews

Prior to the restrictions being lifted, the research team conducted interviews with stakeholders - including representatives from major relevant Scottish and UK trade associations - to gauge the sector's thoughts and feelings around implementing COVID-19 measures in licensed premises.

While businesses expressed a willingness to work within government guidance to protect customers and staff, support consumer confidence and enable a return to trading, the interviews - conducted in May and June - also identified commercial challenges of doing so, including financial implications and a risk of compromising the customer experience.

Interviewees felt that there were factors that would help moderate transmission risks, including existing legal requirements on premises (for example, prohibition on selling to drunk customers); industry expertise in managing customer behaviour, including drunkenness; new norms such as allowing table service only; and public anxiety around COVID-19 generally leading to more responsible behaviours. They acknowledged that staff would need to be trained and skilled in implementing the new measures - but also felt that some customers may not appreciate, or respond to, intervention.

Licensed premises observations

Twenty-nine observations of licensed premises took place in July and August, with the researchers monitoring premises for up to two hours while posing as customers. The study found that:

Venues had introduced new layouts, signage, queuing systems, noise and toilet management, and provided hand sanitising stations - however, stations were infrequently used. Two of the venues routinely administered sanitiser to customers' hands on entry.

Most venues required customers to provide contact details to support contact tracing, however, nine businesses observed did not - including one venue visited after this was made mandatory by the Scottish Government in August.

While staff wore personal protective equipment (PPE) in most venues, in several, staff wore no PPE, wore masks inappropriately, or removed them to talk to other staff or customers.

Most venues distanced their tables by one metre or more, or had installed partitions between booths, however, several had tables closer together than that without partitions.

One-way systems were implemented to help regulate the flow of customers - although this measure was sometimes ignored - and pinch points were problematic in nearly all venues, with entrances, corridors, doorways or bar counter areas leading to bottlenecks and people congregating, often unchallenged. Fewer than half of venues offered table service only - which helps avoid any possibility of queuing for service at the bar - and, in at least one venue observed in July, a continuous queue formed in the one-metre space between tables.

Fewer than half of venues had a basic system (for example, a sign on a door) in place to limit the number of customers entering toilets - while most had no measures to ensure physical distancing inside those areas, with no cubicles or sinks condemned. Overcrowding and poor physical distancing was observed to be a problem within toilet areas in some premises.

Incidents

A wide range of incidents with potential to increase transmission risk were observed in all but three venues, with multiple incidents reported in most. Incidents deemed to be of greater concern - due to the repeated or continuous nature of the potential risk, the large number of customers involved, or the involvement of staff - were observed in eleven venues. These included: various combinations of singing, shouting or playing music; mixing between groups; standing and moving around the bar without distancing; customers taking photographs with other customers and staff; shaking hands or embracing others who did not appear to be in their household. Notably, in all but one of the venues visited in August, customers were witnessed singing loudly or shouting, and with just one example of effective staff intervention to suppress customer noise.

The research team identified factors which interacted to give rise to the more serious incidents, including: physical set up and operation of premises, a social atmosphere, customer behaviour, alcohol consumption and staff practices. All but one of these incidents were observed in the evening; all but two occurred in premises located in a town or village, rather than a city; all but three allowed bar service (rather than table service only); and customers often appeared to be regulars.

In the majority of premises, no staff intervention in incidents or attempts to enforce restrictions were observed. In some cases, staff intervened in a light-hearted way - for example, by gently or playfully reprimanding customers - but such interventions were largely ineffective. Enforcement by external agencies - such as environmental health or police officers - was not observed in any of the venues.

The research report notes that Scottish Government guidance does not go into detail on exactly how bar or security staff might be expected to effectively and safely intervene in customer breaches of distancing, or in the management of situations which would normally require close contact between customers and staff - such as the removal of very drunk or belligerent customers from the premises.

Evidence

Professor Fitzgerald said: "Our study makes a unique contribution by providing the first evidence, including direct observation data, of how premises operated in practice when allowed to reopen during the COVID-19 pandemic. Overall, our findings suggest grounds for uncertainty about the extent to which new rules can be consistently and effectively implemented in a sector where interaction between tables, households and strangers is the norm, and alcohol is routinely consumed.

"Despite the efforts of licensed premises, and detailed guidance from Government, potentially significant risks of COVID-19 transmission persisted in a substantial minority of observed bars - especially when customers were intoxicated. Blanket closures, curfews or alcohol sales bans are more likely to be deemed necessary to control virus spread, if such risks cannot be acceptably, quickly and cost-effectively reduced through support and/or sanctions for premises operators. Such blanket actions may also have benefits in terms of protecting staff from occupational exposure and reducing pressure on emergency services from alcohol-related injuries or disorder. However, attention also needs to be paid to the impact of closures on businesses, economic activity, employee hardship, and ownership patterns in the sector, as well as any risks posed by diversion of some drinking to the home."

Credit: 
University of Stirling

Higher elevation birds sport thicker down "jackets" to survive the cold

image: Sahas Barve, a Peter Buck Fellow at the Smithsonian's National Museum of Natural History, led a new study to examine feathers across 249 species of Himalayan songbirds, finding that birds living at higher elevations have more of the fluffy down--the type of feathers humans stuff their jackets with--than birds from lower elevations. Published on Feb. 15 in the journal Ecography, the study also finds that smaller-bodied birds, which lose heat faster than larger birds, tend to have longer feathers in proportion to their body size and thus a thicker layer of insulation.

Image: 
Suniti Bhushan Datta

Feathers are a sleek, intricate evolutionary innovation that makes flight possible for birds, but in addition to their stiff, aerodynamic feathers used for flight, birds also keep a layer of soft, fluffy down feathers between their bodies and their outermost feathers to regulate body temperature.

Using the Smithsonian's collection of 625,000 bird specimens, Sahas Barve, a Peter Buck Fellow at the Smithsonian's National Museum of Natural History, led a new study to examine feathers across 249 species of Himalayan songbirds, finding that birds living at higher elevations have more of the fluffy down--the type of feathers humans stuff their jackets with--than birds from lower elevations. Published on Feb. 15 in the journal Ecography, the study also finds that smaller-bodied birds, which lose heat faster than larger birds, tend to have longer feathers in proportion to their body size and thus a thicker layer of insulation.

Finding such a clear pattern across so many species underscores how important feathers are to a bird's ability to adapt to its environment and suggests that adding down may be a strategy common to all songbirds, or passerines as they are known to researchers. Furthermore, finding that birds from colder environments tend to have more down may one day help researchers predict which birds are most vulnerable to climate change simply by studying their feathers.

"The Himalayas are seeing some of the fastest rates of warming on Earth," Barve said. "At the same time, climate change is driving an increase in the frequency and intensity of extremely cold events like snowstorms. Being able to accurately predict the temperatures a bird can withstand could give us a new tool to predict how certain species might respond to climate change."

The research was inspired by a tiny bird called a goldcrest during a frigid morning of field work in the Sho-kharkh forest of the Himalayas. Barve found himself wondering how this bird, which weighs about the same as a teaspoon of sugar, was able to flit about the treetops in icy air that was already numbing his fingers. Shoving his hands back into the pockets of his thick down jacket, the question that formed in Barve's mind was "Do Himalayan birds wear down jackets?"

To answer that question, Barve and his co-authors used a microscope to take photos of the chest feathers of 1,715 specimens from the Smithsonian's collections representing 249 species from the cold, high-altitude Himalayan Mountains. Then, Barve and his co-authors used those super-detailed photos to determine exactly how long each feather's downy section was relative to its total length. The team was able to do that by looking at the fluffy downy section of each feather close to its base when compared to the streamlined ends of most birds' feathers.

After meticulously logging the relative lengths of all those downy sections, Barve analyzed the results and found that the smallest birds and the birds from the highest elevations, where temperatures are at their coldest, tended to have the highest proportion of down on their body feathers. The analysis showed that high-elevation birds had up to 25% more down in their feathers, and the smallest bird had feathers that were three times as long as the largest birds, proportionately to their body size.

Past research suggested that birds from colder habitats sported added downy insulation, but Barve said this is the first study to analyze this pattern for such a large number of species in cold environments and across 15,000 feet of elevation.

"Seeing this correlation across so many species makes our findings more general and lets us say these results suggest all passerine birds may show this pattern," Barve said. "And we never would have been able to look at so many different species and get at this more general pattern of evolution without the Smithsonian's collections."

Carla Dove, who runs the museum's Feather Identification Lab and contributed to the study, said she was excited to work together with Barve to use the Smithsonian's collections in a new way. "Sahas looked at more than 1,700 specimens. Having them all in one place in downtown Washington, D.C., as opposed to having to go to the Himalayas and study these birds in the wild, obviously makes a big difference. It allowed him to gather the data he needed quickly before the COVID lockdowns swept the globe, and then work on the analysis remotely."

Barve said he is following up this study with experiments looking into just how much insulation birds get from their feathers and then will tie that to the feather's structure and proportion of down. One day, Barve aims to develop a model that will allow scientists to look at the structure of a feather and predict how much insulation it gives the bird--a capability that could help researchers identify species vulnerable to climate change.

Dove said the potential to use these results to eventually understand how some birds might cope with climate change highlights the importance of museum collections. "We have more than 620,000 bird specimens collected over the past 200 years waiting for studies like this. We don't know what our specimens will be used for down the line; that's why we have to maintain them and keep enhancing them. These specimens from the past can be used to predict the future."

Credit: 
Smithsonian

Cheap, potent pathway to pandemic therapeutics

video: A diverse collections of simulated nanobodies bind to different parts of a protein antigen.

Image: 
Zhe Sang

PITTSBURGH, Feb. 15, 2021 - By capitalizing on a convergence of chemical, biological and artificial intelligence advances, University of Pittsburgh School of Medicine scientists have developed an unusually fast and efficient method for discovering tiny antibody fragments with big potential for development into therapeutics against deadly diseases.

The technique, published today in the journal Cell Systems, is the same process the Pitt team used to extract tiny SARS-CoV-2 antibody fragments from llamas, which could become an inhalable COVID-19 treatment for humans. This approach has the potential to quickly identify multiple potent nanobodies that target different parts of a pathogen--thwarting variants.

"Most of the vaccines and treatments against SARS-CoV-2 target the spike protein, but if that part of the virus mutates, which we know it is, those vaccines and treatments may be less effective," said senior author Yi Shi, Ph.D., assistant professor of cell biology at Pitt. "Our approach is an efficient way to develop therapeutic cocktails consisting of multiple nanobodies that can launch a multipronged attack to neutralize the pathogen."

Shi and his team specialize in finding nanobodies--which are small, highly specific fragments of antibodies produced by llamas and other camelids. Nanobodies are particularly attractive for development into therapeutics because they are easy to produce and bioengineer. In addition, they feature high stability and solubility, and can be aerosolized and inhaled, rather than administered through intravenous infusion, like traditional antibodies.

By immunizing a llama with a piece of a pathogen, the animal's immune system produces a plethora of mature nanobodies in about two months. Then it's a matter of teasing out which nanobodies are best at neutralizing the pathogen--and most promising for development into therapies for humans.

That's where Shi's "high-throughput proteomics strategy" comes into play.

"Using this new technique, in a matter of days we're typically able to identify tens of thousands of distinct, highly potent nanobodies from the immunized llama serum and survey them for certain characteristics, such as where they bind to the pathogen," Shi said. "Prior to this approach, it has been extremely challenging to identify high-affinity nanobodies."

After drawing a llama blood sample rich in mature nanobodies, the researchers isolate those nanobodies that bind specifically to the target of interest on the pathogen. The nanobodies are then broken down to release small "fingerprint" peptides that are unique to each nanobody. These fingerprint peptides are placed into a mass spectrometer, which is a machine that measures their mass. By knowing their mass, the scientists can figure out their amino acid sequence--the protein building blocks that determine the nanobody's structure. Then, from the amino acids, the researchers can work backward to DNA--the directions for building more nanobodies.

Simultaneously, the amino acid sequence is uploaded to a computer outfitted with artificial intelligence software. By rapidly sifting through mountains of data, the program "learns" which nanobodies bind the tightest to the pathogen and where on the pathogen they bind. In the case of most of the currently available COVID-19 therapeutics, this is the spike protein, but recently it has become clear that some sites on the spike are prone to mutations that change its shape and allow for antibody "escape." Shi's approach can select for binding sites on the spike that are evolutionarily stable, and therefore less likely to allow new variants to slip past.

Finally, the directions for building the most potent and diverse nanobodies can then be fed into vats of bacterial cells, which act as mini factories, churning out orders of magnitude more nanobodies compared to the human cells required to produce traditional antibodies. Bacterial cells double in 10 minutes, effectively doubling the nanobodies with them, whereas human cells take 24 hours to do the same.

"This drastically reduces the cost of producing these therapeutics," said Shi.

Shi and his team believe their technology could be beneficial for more than just developing therapeutics against COVID-19--or even the next pandemic.

"The possible uses of highly potent and specific nanobodies that can be identified quickly and inexpensively are tremendous," said Shi. "We're exploring their use in treating cancer and neurodegenerative diseases. Our technique could even be used in personalized medicine, developing specific treatments for mutated superbugs for which every other antibiotic has failed."

Credit: 
University of Pittsburgh